financetom
Business
financetom
/
Business
/
Anti-wrinkle injection maker Revance to go private in $924 million deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Anti-wrinkle injection maker Revance to go private in $924 million deal
Aug 12, 2024 5:36 AM

Aug 12 (Reuters) - Anti-wrinkle injection maker Revance

Therapeutics ( RVNC ) will be acquired by private skincare

company Crown Laboratories in a take-private deal worth $924

million, including debt, the two companies said on Monday.

(Reporting by Leroy Leo in Bengaluru; Editing by Devika

Syamnath)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-RPM Acquires TMP Convert To Expand Decking And Landscaping Offerings
BRIEF-RPM Acquires TMP Convert To Expand Decking And Landscaping Offerings
Nov 3, 2024
Oct 31 (Reuters) - RPM International Inc ( RPM ): * RPM ACQUIRES TMP CONVERT TO EXPAND DECKING AND LANDSCAPING OFFERINGS * RPM INTERNATIONAL INC ( RPM ): TERMS OF TRANSACTION WERE NOT DISCLOSED Source text: Further company coverage: ...
HF Sinclair reports Q3 loss amid refining margin slump
HF Sinclair reports Q3 loss amid refining margin slump
Nov 3, 2024
Oct 31 (Reuters) - Refiner HF Sinclair reported a loss in the third quarter compared to a year-ago profit on Thursday, hurt by a slump in margins, especially in the West and Mid-Continent regions, due to an oversupply of fuel. The Dallas-based refiner posted a loss of $75.9 million, or 40 cents per share, for the quarter ended September 30,...
Brewers volumes disappoint as drinkers buy less beer
Brewers volumes disappoint as drinkers buy less beer
Nov 3, 2024
LONDON/COPENHAGEN (Reuters) -Two of the biggest brewers Anheuser-Busch InBev and Carlsberg sold less than forecast in the third quarter as consumers, particularly in China, cut their spending by drinking less or choosing cheaper beer. The world leader AB InBev's profits and revenues fell short of analyst expectations, sending its shares almost 4% lower as a $2 billion share buyback and...
Cigna Group Q3 Adjusted Earnings, Revenue Increase; Reiterates 2024 Adjusted EPS Guidance
Cigna Group Q3 Adjusted Earnings, Revenue Increase; Reiterates 2024 Adjusted EPS Guidance
Nov 3, 2024
06:51 AM EDT, 10/31/2024 (MT Newswires) -- Cigna Group ( CI ) reported Q3 adjusted earnings Thursday of $7.51 per diluted share, up from $6.77 a year earlier. Analysts polled by Capital IQ expected $7.25. Revenue for the quarter ended Sept. 30 was $63.69 billion, up from $49.05 billion a year earlier. Analysts surveyed by Capital IQ expected $59.59 billion....
Copyright 2023-2026 - www.financetom.com All Rights Reserved